Brain morphological changes and early marijuana use: A magnetic resonance and positron emission tomography study

Journal of Addictive Diseases

Volumn 19, Issue 1, 2000, Pages 1-22

  Wilson, William ^a   Mathew, Roy ^a   Turkington, Timothy ^a   Hawk, Thomas ^a   Coleman, R Edward ^a   Provenzale, James ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adolescence; Brain morphology; Cerebral blood flow (CBF); Mangetic Resonance Imaging (MRI); Marijuana (THC); Positron Emission Tomography (PET)

Indexed keywords

CANNABIS; HYPOPHYSIS HORMONE; SEX HORMONE; WATER O 15;

ADULT; ARTICLE; BRAIN; BRAIN BLOOD FLOW; BRAIN SIZE; DRUG EXPOSURE; DRUG USE; FEMALE; GRAY MATTER; HUMAN; LATERAL BRAIN VENTRICLE; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; POSITRON EMISSION TOMOGRAPHY; WHITE MATTER;

ADOLESCENT; ADULT; AGE FACTORS; BODY CONSTITUTION; BRAIN; CANNABINOIDS; CEPHALOMETRY; CEREBRAL CORTEX; CEREBRAL VENTRICLES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA ABUSE; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033838024     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v19n01_01     Document Type: Article

References (73)

1. Pope HG, Gruber AJ, Yargelun-Todd D. The residual neuropsychological effects of cannabis: the current status of research. Drug and Alcohol Dependence. 1995; 38:25-34.
2. Block RI. Does heavy marijuana smoking impair human cognition and brain function? JAMA. 1996; 275:560-561.
3. University of Michigan. Drug use rises again in 1995 among American teens (press release from the Monitoring the future study). Ann Arbor, Michigan; December 11, 1995.
4. Pope HG, Yargelun-Todd D. The residual effects of heavy marijuana use in college students. JAMA. 1996; 275(7):521-527.
5. Fletcher JM, Page JB, Francis DJ, Copeland K, Naus MJ, Davis CM, Morris R, Krauskopf D, Satz P. Cognitive correlates of long-term cannabis use in Costa Rican men. Arch Gen Psychiatry. 1996; 53:1051-1057.
6. Campbell AMG, Evans M, Thomsom J, Williams M. Cerebral atrophy in young cannabis smokers. Lancet. 1971; 2:1219-1225.
7. Co BT, Goodwin D, Gado M, Mikhael M, Hill S. Absence of cerebral atrophy in chronic cannabis users: evaluation by computerized transaxial tomography. JAMA. 1977; 237(12):1229-1230.
8. Hannerz J, Hindmarsh T. Neurological and neuroradiological examination of chronic cannabis smokers. Annals of Neurol. 1982; 13(2):207-210.
9. Kuehnle J, Mendelson J, Davis K, New P. Computed tomographic examination of heavy marijuana smokers. JAMA. 1977; 237:1231-1232.
10. DeCarli C, Maisog J, Murphy DGM, Teichberg D, Rapoport SI, Horwits B. Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images. J Comp Assist Tomog. 1992; 16(2):274-284.
11. Mathew RJ, Wilson WH, Coleman RE, Turkington TG, DeGrado TR. Marijuana intoxication and brain activation in marijuana smokers. Life Science. 1997; 60(23):2075-2089.
12. Spitzer RL, Williams JBW, Gibbon M, First MB. User’s Guide for the Structured Clinical Interview for the DSM-III-R. American Psychiatric Press, Inc.; 1984.
13. Skinner HA. Drug Abuse Screening Test. Addict Behav. 1982; 7:363.
14. Pokorny AD, Miller BA, Kaplan HB. The brief MAST: A shortened version of the Michigan Alcoholism Screening Test. Am J Psychiatry. 1972; 129(3):342-345.
15. Beck AT, Beck RW. Screening depressed patients in family practice. Post-grad Med. 1972; 52:81-85.
16. Spielberger CD, Gorsuch RL, Lushene RD. STAI Manual. Consulting Psychologist Press: Palo Alto, California; 1970.
17. Byrum CE, MacFall JR, Charles HC, Chitilla VR, Boyko OB, Upchurch L, Smith JS, Rajagopalan P, Passe T, Kim D, Xanthakos S, Krishnan KRK. Accuracy and reproducibility of brain and tissue volumes using a magnetic resonance segmentation method. Psychiatry Res: Neuroimaging. 1996; 67:215-234.
18. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. New York: Thieme Medical Publishers, Inc; 1988.
19. Kretschmann H-J, Weinrich W. Clinical Neuroimaging and Clinical Neuro- anatomy:Magnetic Resonance Imaging and Computed Tomography, (2nd ed). New York: Georg Thieme, Verlag Stuttgart; 1992.
20. Eichling JO, Raichle ME, Grubb RL, JR, Ter-Pogossian MM. Evidence of the limitations of water as a freely diffusible tracer in brain of monkey. Circ Res. 1974; 35:358-364.
21. Frackowiak RS, Lenzi GL, Jones G, Heather JD. Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: Theory, procedure and normal values. J Comput Assist Tomography. 1980; 4:727-736.
22. Huang SC, Carson RE, Hoffman EJ, Carson J, MacDonald N, Barrio JR, Phelps ME. Quantitative measurement of local cerebral blood flow in humans by positron emission tomography and 15 O-water. J Cereb Blood Flow Metab. 1983; 3:141-153.
23. Meyer E. Simultaneous correction for tracer arrival delay and dispersion in CBF measurements by the H2 15O autoradiographic method and dynamic PET. J Nuclear Med. 1989; 30:1069-1078.
24. Chen CT, Pelizzari CA, Chen TY, Hu X, Lebin DN, Cooper MD. Integration of brain images from multiple modalities. J Cereb Blood Flow Metab. 1989; 9(1):S402.
25. Pelizzari CA, Chen GTY, Spelbring DR, Weichsebaum RR, Chen CT. Accurate three-dimensional registration of CT, PET and/or MR images of the brain. J Comput Assist Tomog. 1989; 13:20-26.
26. Turkington TG, Jasczak RJ, Pelizzari CA, Harris CC, McFall JR, Hoffman JM, Coleman RE. Accuracy of registration of PET, SPECT and MR images of a brain phantom. J Nuclear Med. 1993; 34(9):1587-1594.
27. Turkington TG, Hoffman JM, Jasczak RJ, MacFall JR, Harris CG, Kilts CD, Pelizzari CA, Coleman RE. Accuracy of surface fit registration for PET and MR images using full and incomplete brain surfaces. J Comput Assist Tomog. 1995; 19(1):117-124.
28. Kirk RE. Experimental Design: Procedures for the Behavioral Sciences. 2nd Ed. Belmont, CA; Brooks/Cole;1982.
29. Yoshii F, Barker WW, Chang JY, et al. Sensitivity of cerebral glucose metabolism to age, sex, brain volume, brain atrophy, and cerebrovascular risk factors. J Cer- eb Blood Flow Metab. 1988; 8:654-661.
30. Scallet AC, Uemura E, Andrews A, Ali SF, McMillan DE, Paule MG, Brown RM, Slikker W, Jr. Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC). Brain Res. 1987; 436:193-198.
31. Jernigan TL, Tallal P. Late childhood changes in brain morphology observable with MRI. Devel Med Child Neurology. 1990; 32:379-385.
32. Herkenham M. Cannabinoid receptor localization in brain: relationship to motor and reward systems. Ann New York Acad Sci. 1992; 654:19-32.
33. Dekaban AS, Sadowsky D. Changes in brain weights during the span of human life: relation of brain weights to body heights and weights. Ann Neurol. 1978; 4:345-356.
34. Dobbing J, Sands J. Quantitative growth and development of human brain. Arch Dis Childhood. 1973; 48:757-767.
35. Jernigan TL, Trauner DA, Hasselink JR, Tallal PA. Maturation of human cerebrum observed in vivo during adolescence. Brain. 1991; 114:2037-2049.
36. Reiss AL, Abrams MT, Singer HS, Ross JL, Denckla MB. Brain development, sex and IQ in children. A volumetric imaging study. Brain. 1996; 119:1763-1774.
37. Purves D. Body and Brain: A Tropic Theory of Neural Connections. Cambridge, MA and London: Harvard University Press; 1988.
38. Hoffman MA, Swabb DF. Sexual dimorphism of the human brain: myth and reality. Exp Clin Endocrinology. 1991; 98:161-170.
39. Witelson SF. Neural sexual mosaicism: sexual differentiation of the human temporoparietal region for functional asymmetry. Psychoneuroendocrinology. 1991; 16:131-133.
40. Clark AS, Goldman-Rakic PS. Gonadal hormones influence the emergence of cortical function in nonhuman primates. Behavioral Neuroscience. 1989; 103(6): 1287-1295.
41. Wenger T, Croix D, Tramu G, Leonardelli J. Effects of delta-9-tetrahydrocan- nabinol on pregnancy, puberty and the neuroendocrine system. In: L Murphy and A Bartke, eds. Marijuana/Cannabinoids: Neurobiology and Neurophysiology. Boca Raton; CRC Press, Inc.; 1992.
42. Cone EJ, Johnson RE, Moore JD, Roache JD. Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects. Pharmacol, Biochem & Behavior. 1986; 24:1749-1754.
43. Mendelson JH, Mello NK, Ellingboe J, Skupny AST, Lex BW, Griffin M. Marihuana smoking suppresses luteinizing hormone in women. J Pharmacology & Exp Therapeutics. 1986; 237(3):862-866.
44. Schlaepfer TE, Harris GJ, Tien AY, Peng L, Lee S, Pearlson GD. Structural differences in the cerebral cortex of healthy female and male subjects: a magnetic resonance imaging study. Psych Res Neuroimaging. 1995; 61:129-135.
45. Murphy DGM, DeCarli C, McIntosh AR, Daly E, Mentis M, Pietrini P, Szcze- panik J, Schapiro MB, Grady CL, Horwitz B, Rapoport SI. Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effects of aging. Arch Gen Psychiatry. 1996; 53:585-594.
46. Fernandez-Ruiz JJ, Rodriguez de Fonseca F, Navarro M, Ramos JA. Maternal cannabinoid exposure and brain development: changes in the ontogeny of dopamine neurons. In: L Murphy and A Bartke, eds. Marijuana/Cannabinoids: Neurobiology and Neurophysiology. Boca Raton; CRC Press, Inc.; 1992.
47. Walters DE, Carr LA. Perinatal exposure to cannabinoids alters neurochemical development of the brain. Pharmacol Biochem Behav. 1988; 29:213.
48. Klausner HA, Dingle JV. The metabolism and excretion of delta-9-tetrahydro- cannabinol in the rat. Life Sci. 1971; 10:49.
49. Stiglick A, Kalant H. Residual effects of chronic cannabis treatment on behavior in mature rats. Psychopharmacology. 1985; 85:436.
50. Landfield PW, Cadwallader LB, Vincent S. Quantitative changes in hippocampal structure following long-term exposure to delta-9-tetrahydrocannabinol: Possible mediation by glucocorticoid systems. Brain Res. 1988; 443:47-62.
51. Slikker W, Paule MG, Ali SF, Scallett AC, Bailey JR. Behavioral, neurochemical and neurohistological effects of chronic marijuana smoke exposure in the nonhuman primate. Chap 7. In: Murphy L and Bartke A, eds. Marijuana/Cannabinoids: Neurobiology and Neurophysiology. Boca Raton: CRC Press, Inc.; 1992.
52. Compton DR, Martin BR. Marijuana Neurotoxicology in Handbook of Neurotoxicology. In: Chang LW and Dyer RS, eds. New York: Ch. 29, Marcel Dekker, Inc.; 1995.
53. Nye JS, Voglmaier S, Martinson RE, Snyder SH. Myelin basic protein is an endogenous inhibitor of the high-affinity cannabinoid binding site in brain. J Neurochem. 1988; 50:1170-1178.
54. Gur RC, Gur RE, Obrist WD et al. Sex and handedness differences in cerebral blood flow during rest and cognitive activity. Science. 1982; 217:659-661.
55. Mathew RJ, Wilson WH, Tant S. Determinants of resting regional cerebral blood flow in normal subjects. Biol Psychiatry. 1986; 21:907-914.
56. Esposito G, Van Horn JD, Weinberger DR, Berman KF. Sex differences in cerebral blood flow as a function of cognitive state with PET. J Nucl Med. 1996; 37:559-564.
57. Mazziotta JC. PET scanning principles and applications. Discussions in Neurosci. 1985; 2(1):9-47.
58. Raichle ME, Grubb RL, Gado MH, et al. Correlations between regional cerebral blood flow and oxidative metabolism. Arch Neurol. 1976; 33:523-526.
59. Roland PE. Brain Activation. (Chapter 18). New York: Wiley Liss, Inc.; 1993.
60. Chugani HT, Phelps ME, Mazziota JC. Positron emission tomography study of human brain functional development. Ann Neurol. 1987; 22:487-497.
61. Chiron C, Raynaud C, Maziere B, Zilbovicius M, Laflamme L, Masure M-C, Dulac O, Bourguignon M, Syrota A. Changes in regional cerebral blood flow during brain maturation in children and adolescents. J Nucl Med. 1992; 33(5):696-703.
62. Ogawa A, Sakurai Y, Kayama T, Yoshimoto T. Regional cerebral blood flow with age: changes in rCBF in childhood. Neurol Res. 1989; 11:173-176.
63. Kety SS. Human cerebral blood flow and oxygen consumption as related to aging. J Chronic Dis. 1956; 3:478-486.
64. Goldman H, Skelley EB, Sandman CA, Kastin AJ, Murphy S. Hormones and regional brain blood flow. Pharmaco Biochem Behav. 1976; 5 (suppl 1):165-169.
65. Ohkura T, Teshima Y, Isse K, Matsuda H, Inoue T, Sakai Y, Iwasaki N, Yaoi Y. Estrogen increases cerebral and cerebellar blood flows in postmenopausal women. J North Amer Menopause Soc. 1995; 2(1):13-18.
66. Devous MD, Stokley EM, Chehabi HH, Bonte FJ. Normal distribution of regional blood flow measured by dynamic single-photon emission tomography. J Cereb Blood Flow Metab. 1986; 6:95-104.
67. Swihart AA, Mathew RJ, Lorgen JW. Menstruation and cerebral blood flow. Biological Psychiatry. 1989; 25:654-657.
68. Kokka N, Garcia JF. Effects of delta-9 tetrahydrocannabinol on growth hormone and ACTH secretion in rats. Life Science. 1974; 15:329.
69. Rettori V, Wenger T, Snyder G, Dalterio S, McCann SM. Hypothalamic action of delta-9-tetrahydrocannabinol to inhibit the release of prolactin and growth hormone in rat. Neuroendocrinology. 1988; 47:498.
70. Ingersoll, GM. Adolescents. 2nd ed. Englewood Cliffs, New Jersey: Prentice Hall; 1988.
71. Comerci, GD. Normal pubescent growth and sexual maturation. Seminars Adolescent Medicine. 1987; 3(1):217-226.
72. Gupta D, Elbracht C. Effects of tetrahydrocannabinols on pubertal body weight spurt and sex hormones in developing male rats. Res Exper Med. 1983; 182:95-104.
73. Field E, Tyrey L. Delayed sexual maturation during prepubertal cannabinoid treatment: importance of the timing of treatment. J Pharmaco Exper Therap. 1990; 254(1):171-175.